David Krause

Randomized, Double-Blind Comparison of Once-Weekly Dalbavancin versus Twice-Daily Linezolid Therapy for the Treatment of Complicated Skin and Skin Structure Infections

L. E. Jauregui, S. Babazadeh, Elyse Seltzer et al. · Clinical Infectious Diseases · 2005 · 309 citations · Full text

Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease

Emmet B. Keeffe, Sten Iwarson, Brian J. McMahon et al. · Hepatology · 1998 · 271 citations · Full text

Healthy Subjects, Immunology, Hepatitis B +19

Population Pharmacokinetic Analysis of Anidulafungin, an Echinocandin Antifungal

James A. Dowell, William Knebel, Tom Ludden et al. · The Journal of Clinical Pharmacology · 2004 · 168 citations

Serious Fungal Disease, Analysis Population, Antifungal Agent +8

A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: The oral calcitonin in postmenopausal osteoporosis (ORACAL) trial

Neil Binkley, Michael A. Bolognese, Anna Sidorowicz-Białynicka et al. · Journal of Bone and Mineral Research · 2012 · 145 citations · Full text

Oral Calcitonin, Pharmacotherapy, Oral Rsct +16

Anidulafungin Does Not Require Dosage Adjustment in Subjects With Varying Degrees of Hepatic or Renal Impairment

James A. Dowell, Martin Stogniew, David Krause et al. · The Journal of Clinical Pharmacology · 2007 · 112 citations